Immunomodulation for stroke-associated pneumonia: a systematic review of mechanistic insight and emerging therapeutic strategies in animal models - Summary - MDSpire

Immunomodulation for stroke-associated pneumonia: a systematic review of mechanistic insight and emerging therapeutic strategies in animal models

  • By

  • Xiangyun Chen

  • Yihe Xu

  • Yonghong Gao

  • Xinxing Lai

  • Rufan Xu

  • Hongrui Zhang

  • Na Li

  • Zhenhong Liu

  • Ying Gao

  • July 16, 2026

Share

Objective:

To systematically summarize key cellular and molecular immune mechanisms underlying the development and progression of stroke-associated pneumonia (SAP) and to critically discuss current pharmacological strategies targeting the immune system for preventing or treating SAP.

Approach:
  • Search Strategy: Systematic search of PubMed, Scopus, Web of Science, and Embase for studies on immune mechanisms and immunomodulatory therapies for SAP, following PRISMA guidelines.
  • Eligibility Criteria: Included studies focused on experimental stroke models evaluating pulmonary inflammation or lung infection, immune mechanisms related to pneumonia post-stroke, and therapeutic approaches targeting the immune system.
  • Data Extraction: Data was independently extracted and verified by researchers from the included studies, focusing on various categories such as author, year of publication, animal species, model, and primary outcomes.
Key Findings:
  • Stroke severity disrupts immune homeostasis, leading to SAP through a multi-layered network.
  • Systemic immunosuppression is primarily mediated by sympathetic nervous system overactivation, causing splenic atrophy and lymphocyte apoptosis.
  • Sustained activation of the cholinergic anti-inflammatory pathway may impair pulmonary antimicrobial defense.
  • Disruption of the gut-lung axis and local pulmonary alterations are implicated in SAP development.
  • Interventions targeting immune mechanisms, such as iNKT cell activators, show promise in preclinical models.
Interpretation:

The review synthesizes the mechanistic basis of SAP and identifies emerging immunomodulatory interventions, emphasizing the need for further validation of these strategies in clinical settings.

Limitations:
  • The review protocol was not prospectively registered, affecting transparency.
  • Most immunomodulatory strategies discussed remain experimental and require further validation for clinical application.
Conclusion:

The review highlights the urgent need for a systematic integration of existing evidence and the development of innovative strategies against SAP.

Original Source(s)

Related Content